Swamy Yeleswaram
Vermögen: 10 Mio $ am 31.05.2026
Vermögen: 10 Mio $ am 31.05.2026
Swamy Yeleswaram was the founder of Incyte Corp., founded in 2002, and held the title of Group Vice President-Drug Metabolism from 2016 to 2022.
Dr. Yeleswaram currently holds the position of Chief Development Officer at Rapport Therapeutics, Inc. since 2023.
Dr. Yeleswaram's education includes a doctorate from the University of British Columbia, a graduate degree from Banaras Hindu University, and an undergraduate degree from Madras Medical College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.04.2026 | 246.426 ( 0,52 % ) | 10 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| RAPPORT THERAPEUTICS, INC. | Corporate Officer/Principal | 01.01.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
| INCYTE CORPORATION | Gründer | 01.08.2022 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Banaras Hindu University
Banaras Hindu University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madras Medical College
Madras Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Operates as an clinical-stage biotechnology company that engages in discovery and development of medicines for neurological disorder | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen